RE: T-minus 10 and counting22 Feb 2023 13:08
Hat tip to 1gw...
HVO may have a background role, but it looks as though the quarantining will be done elsewhere:
https://www.imperial.ac.uk/infectious-disease/research/human-challenge/covhic002/
and here's an explanation for the slowness in follow-through:
health-and-wellbeing/human-challenge-studies-what-weve-learned-from-intentionally-infecting
.."Could the challenge agent have been created more quickly? Perhaps, but with SARS-CoV-2, the high level of community infections meant that more traditional placebo-controlled studies (where people are given either an active or inactive vaccine and subsequent infections are recorded) were far more effective, and easy to conduct, for scientists trying to develop vaccines.
So, contrary to many people’s expectations, and despite their track record in accelerating vaccine development for diseases such as malaria, the SARS-CoV-2 challenge studies didn’t speed up the immediate development of vaccines.
The studies are, however, still very useful, as they were able to follow the infection closely from first exposure through to the development of symptoms and subsequent recovery. They revealed just how infectious the virus is, as participants exposed to even the smallest dose became infected. They also provided a useful validation of the sensitivity of rapid antigen tests..."